About Sonic Clinical Trials


Sonic Clinical Trials (SCT) is a wholly owned subsidiary of Australian-owned Sonic Healthcare Limited, one of the world's largest specialist medical diagnostics companies, employing more than 27,000 people in Australia, New Zealand, the United Kingdom, Germany, Switzerland, Belgium, Ireland and the USA.

SCT provides a dedicated, superior central laboratory service, exclusively in support of Phase I-IV clinical trials, safety testing and patient monitoring services to the Pharmaceutical, Biotechnology and Research organisations in the Asia Pacific region. Sonic's sister clinical trial laboratory, TDL Trials based in London, provides extended services and capabilties throughout the United Kingdom and continental Europe. Together, we aim to meet every client's unique requirements, by offering flexible service options, high-quality results through technical excellence and local project management, whilst ensuring all regulatory requirements are met.

Meet the Clinical Trials Team! 

Click to learn more about Sonic Clinical Trials


In addition to the depth of experience of the Australian central laboratory team, Sonic Clinical Trials can directly access the vast infrastructure and resources of Sonic Healthcare's extended group of diagnostic practices, to provide an even broader range of services and medical expertise.  

The group's management team has a unique depth of central laboratory experience, providing direct flow-on benefits to its clients.


What's New?

Sonic Clinical Trials is a registered Research Service Provider (RSP) with AusIndustry which allows us to work with and assist our international clients register for the Australian R&D Tax Incentive Scheme. Eligible companies may claim an R&D tax offset (up to 45%) for eligible expenditure on registered R&D activities.

Working with Sonic Clinical Trials as a registered RSP helps companies, particularly small to mid-size companies gain access to expert R&D resources in particular fields. Any questions on how we could assist in an upcoming study in Australia, please contact us.


Biomarker testing

Wide range of biomarker testing now available in the SCT laboratory including:


• Glucagon • Inhibin B • Proinsulin • Pancreatic polypeptide • Pancreatic peptide YY • Sonic Hedgehog Ligand • Interleukin 1β • Osteopontin

• Glucagon-like peptide 1 (Active/Total) • Transforming Growth Factor beta-1 • Tumor Necrosis Factor alpha • Vascular Endothelial Growth Factor

• Inflammatory markers (C-Reactive Protein, Interleukin-6) • Tumour markers (CA 125, CA 15-3, CA 19-9, CEA, AFP, PSA, BHCG, Prolactin, Thyroglobulin, Chromogranin-A)


Please contact us for any special biomarker needs.